Form 4 for CNMD CONMED Corp
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001127602-22-008106 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-03 | 2022-03-01+ | CNMD | KENNEDY JOHN JED | Group EVP | M - OptEx | $26.40 | +8,968 | 10.2K | +750% | +$236.8K |
| DM | 2022-03-03 | 2022-03-01 | CNMD | KENNEDY JOHN JED | Group EVP | F - Tax | $144.55 | -1,070 | 9,855 | -10% | -$154.7K |
| DM | 2022-03-03 | 2022-03-02 | CNMD | KENNEDY JOHN JED | Group EVP | S - Sale+OE | $145.50 | -5,418 | 9,855 | -35% | -$788.3K |
| DM | 2022-03-03 | 2022-03-01+ | CNMD | KENNEDY JOHN JED | Group EVP | M - OptEx | $0.00 | -8,968 | 10.5K | -46% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-02 | M | A | 5,000 | $41.93 | 14,855 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-01 | F | D | 394 | $144.55 | 8,231 | D | — | — | |
| 3 | Common | Common Stock | 2022-03-01 | M | A | 1,250 | $0.00 | 8,625 | D | — | — | |
| 4 | Common | Common Stock | 2022-03-02 | S | D | 110 | $145.50 | 9,855 | D | — | — | |
| 5 | Common | Common Stock | 2022-03-02 | M | A | 110 | $78.76 | 9,965 | D | — | — | |
| 6 | Common | Common Stock | 2022-03-01 | M | A | 1,250 | $0.00 | 9,481 | D | — | — | |
| 7 | Common | Common Stock | 2022-03-01 | F | D | 367 | $144.55 | 9,114 | D | — | — | |
| 8 | Common | Common Stock | 2022-03-01 | M | A | 1,050 | $0.00 | 10,164 | D | — | — | |
| 9 | Common | Common Stock | 2022-03-01 | F | D | 309 | $144.55 | 9,855 | D | — | — | |
| 10 | Common | Common Stock | 2022-03-02 | S | D | 5,000 | $145.50 | 9,855 | D | — | — | |
| 11 | Common | Common Stock | 2022-03-02 | M | A | 308 | $59.96 | 10,163 | D | — | — | |
| 12 | Common | Common Stock | 2022-03-02 | S | D | 308 | $145.50 | 9,855 | D | — | — | |
| 13 | Derivative | Rsus (restricted Stock Units) | 2022-03-01 | M | D | 1,250 | $0.00 | 1,250 | D | $0.00 · — to 2029-03-01 | 1,250 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. |
| 14 | Derivative | Rsus (restricted Stock Units) | 2022-03-01 | M | D | 1,250 | $0.00 | 2,500 | D | $0.00 · — to 2030-03-02 | 1,250 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. |
| 15 | Derivative | Rsus (restricted Stock Units) | 2022-03-01 | M | D | 1,050 | $0.00 | 3,150 | D | $0.00 · — to 2031-03-01 | 1,050 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. |
| 16 | Derivative | Options To Purchase Common Stock | 2022-03-02 | M | D | 5,000 | $0.00 | 0 | D | $41.93 · — to 2027-03-01 | 5,000 Common Stock | (F2) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |
| 17 | Derivative | Options To Purchase Common Stock | 2022-03-02 | M | D | 110 | $0.00 | 5,590 | D | $78.76 · — to 2029-03-01 | 110 Common Stock | (F3) The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |
| 18 | Derivative | Options To Purchase Common Stock | 2022-03-02 | M | D | 308 | $0.00 | 10,492 | D | $59.96 · — to 2028-03-01 | 308 Common Stock | (F2) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |